BE699393A - - Google Patents

Info

Publication number
BE699393A
BE699393A BE699393DA BE699393A BE 699393 A BE699393 A BE 699393A BE 699393D A BE699393D A BE 699393DA BE 699393 A BE699393 A BE 699393A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE699393A publication Critical patent/BE699393A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE699393D 1966-06-07 1967-06-02 BE699393A (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR64481A FR5519M (sv) 1966-06-07 1966-06-07
FR75528A FR1514122A (fr) 1966-06-07 1966-09-07 Dérivés stéroïdes substitués en position 11 à noyau a aromatique et procédé de préparation
FR86879A FR6021M (sv) 1966-06-07 1966-12-09
FR91611A FR6030M (sv) 1966-06-07 1967-01-18
FR96848A FR6182M (sv) 1966-06-07 1967-02-28
FR98154A FR1540942A (fr) 1966-06-07 1967-03-09 Dérivés stéroïdes substitués en positions 11 et 17 à noyau a aromatique et procédé de préparation

Publications (1)

Publication Number Publication Date
BE699393A true BE699393A (sv) 1967-12-04

Family

ID=27546052

Family Applications (2)

Application Number Title Priority Date Filing Date
BE699393D BE699393A (sv) 1966-06-07 1967-06-02
BE699394D BE699394A (sv) 1966-06-07 1967-06-02

Family Applications After (1)

Application Number Title Priority Date Filing Date
BE699394D BE699394A (sv) 1966-06-07 1967-06-02

Country Status (14)

Country Link
US (2) US3526648A (sv)
AT (3) AT279815B (sv)
BE (2) BE699393A (sv)
CH (3) CH475965A (sv)
DE (1) DE1618830C3 (sv)
DK (2) DK119925B (sv)
ES (5) ES341435A1 (sv)
FR (6) FR5519M (sv)
GB (2) GB1151404A (sv)
IL (2) IL28112A (sv)
NL (2) NL6707906A (sv)
SE (2) SE335979B (sv)
SU (2) SU483828A3 (sv)
YU (6) YU33880B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2140258B1 (sv) * 1971-06-07 1974-08-23 Roussel Uclaf
US3906096A (en) * 1971-11-23 1975-09-16 Roussel Uclaf Novel 11{62 -alkoxy steroids
FR2183555B1 (sv) * 1972-05-10 1975-06-20 Roussel Uclaf
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
FR2401173A1 (fr) * 1977-06-27 1979-03-23 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
US4636496A (en) * 1984-03-20 1987-01-13 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4668668A (en) * 1984-03-20 1987-05-26 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4568673A (en) * 1984-03-20 1986-02-04 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
WO2002022645A2 (en) * 2000-09-14 2002-03-21 Accelerated Pharmaceuticals, Inc. Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10400006B2 (en) 2014-11-26 2019-09-03 The Regents Of The University Of California Estrogen receptor modulators
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Also Published As

Publication number Publication date
ES351368A1 (es) 1969-06-01
YU175867A (en) 1977-12-31
FR1540942A (fr) 1968-10-04
GB1152226A (en) 1969-05-14
DE1618830A1 (de) 1972-04-13
ES341435A1 (es) 1968-07-01
YU33880B (en) 1978-06-30
IL28112A (en) 1973-08-29
CH490361A (fr) 1970-05-15
YU33883B (en) 1978-06-30
ES350987A1 (es) 1969-05-16
SU432714A3 (sv) 1974-06-15
YU54568A (en) 1978-02-28
AT279815B (de) 1970-03-25
GB1151404A (en) 1969-05-07
ES344805A1 (es) 1968-11-01
DK119925B (da) 1971-03-15
AT301037B (de) 1972-08-25
DE1618829A1 (de) 1971-01-14
SE335980B (sv) 1971-06-21
YU33882B (en) 1978-06-30
IL28113A (en) 1973-08-29
YU45568A (en) 1977-12-31
SU483828A3 (ru) 1975-09-05
CH474495A (fr) 1969-06-30
US3579545A (en) 1971-05-18
BE699394A (sv) 1967-12-04
AT290023B (de) 1971-05-10
NL6707906A (sv) 1968-03-08
YU240867A (en) 1977-08-31
US3526648A (en) 1970-09-01
ES348057A1 (es) 1969-03-01
YU33725B (en) 1978-02-28
FR6021M (sv) 1968-05-13
DE1618830B2 (de) 1974-07-04
DK121857B (da) 1971-12-13
FR1514122A (fr) 1968-02-23
FR6030M (sv) 1968-05-13
YU33972B (en) 1978-09-08
SE335979B (sv) 1971-06-21
YU34050B (en) 1978-10-31
DE1618830C3 (de) 1975-02-20
FR5519M (sv) 1967-11-06
FR6182M (sv) 1968-07-15
NL6707903A (sv) 1967-12-08
CH475965A (fr) 1969-07-31
DE1793738B2 (de) 1975-11-27
YU10968A (en) 1978-05-15
YU112567A (en) 1977-12-31
DE1793738A1 (de) 1973-01-11

Similar Documents

Publication Publication Date Title
AU5917865A (sv)
AU428063B2 (sv)
AU424443B2 (sv)
AU414526B2 (sv)
AU417216B2 (sv)
AU433222B2 (sv)
AU421822B2 (sv)
AU415165B1 (sv)
AU5895065A (sv)
AU6703465A (sv)
AU612166A (sv)
AU1111066A (sv)
AU1144366A (sv)
AU218666A (sv)
BE284991A (sv)
BE597652A (sv)
AU433620A (sv)
BE674792A (sv)
NL6707903A (sv)
AU415780B2 (sv)
BE674882A (sv)
AU407778B2 (sv)
AU6852465A (sv)
AU855865A (sv)
AU92366A (sv)